Hi,

Why is there NO revenue shown for BioAgra for the last 3 months?

It is unconscionable that management would tout Mid-South and then show no results. And worse yet is the fact that they haven't even addressed the matter with shareholders.

Am I missing something? Have shareholders been deceived once again?

It makes me laugh to read about more financing deals. More preferred stock.... you've got to be kidding. A revolving line of credit..... for what? Without sales, why continue dumping more cash into this company. How many more people can actually be lining up to buy more preferred shares? If history repeats itself, the share price may rise.... and then fall quickly. Unless investors are shorting against those shares....what value do they have after the restrictions are lifted.

I know that ExypnoTech is generating sales. If I am reading the 10Q correctly, 49% of last quarter's net income is $43,383, and that amount is reflected in the $641,722 owed to Vyta by EPT. But when, exactly, can shareholders in Vyta expect to see payment for those receivables?

It is hard to believe that nothing has changed in 7 years. Even though here's always a new twist, the end result is the same.

Are there only a few of us shareholders who really feel this way? If so.... what are we missing?

Jeff